The reimbursement for expensive medicines: stakeholder perspectives on the SMA medicine nusinersen and the Dutch Coverage Lock policy

• Asıl Yazarlar: Féline E. V. Scheijmans (Yazar), Margot L. Zomers (Yazar), Sina Fadaei (Yazar), Marthe R. Onrust (Yazar), Rieke van der Graaf (Yazar), Johannes J. M. van Delden (Yazar), W. Ludo van der Pol (Yazar), Ghislaine J. M. W. van Thiel (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: BMC, 2022-11-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract Background The reimbursement for expensive medicines poses a growing challenge to healthcare worldwide. In order to increase its control over the costs of medicines, the Dutch government introduced the Coverage Lock (CL) policy in 2015. The CL postpones decisions regarding reimbursement of...